Drug licences of 9 pharma dealers suspended in Jammu

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, the official said

Jammu:  Authorities here on Saturday suspended drug sale licences of nine dealers in a special drive carried out to curb misuse of pharmaceuticals with habit forming ingredients, an official said.

The drive was conducted by the J-K Drugs and Food Control Organisation to identify and take punitive action against “unscrupulous elements dealing with such drugs in a clandestine manner,” an official spokesperson said.

During the drive, it emerged that some wholesale dealers were procuring certain pharma preparations containing Pregabalin as an active ingredient, which is prone to addiction, he said.

The ingredient was being sourced directly from the suppliers based outside Jammu and Kashmir illegally, he said.

More scrutiny revealed that the firms procured and distributed these medicinal preparations without maintaining the sales records as mandated under the Drugs & Cosmetics Act, 1940, the spokesperson said. S

Stocks of pharmaceutical preparations, which are prone to addiction, worth over Rs 13.58 lakh were also seized, he said.

J-K State Drugs Controller Lotika Khajuria warned against indulging in procuring lesser-known brands of drugs formulations consisting of habit forming ingredients directly from the suppliers, or manufacturers located outside J-K.

“In case any violation is reported, the defaulters shall be dealt strictly in accordance with zero-tolerance policy adopted by the government against persons involved in promoting drug abuse which warrants the cancellation of such licences as also legal mandate,” she said.

Related Posts

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

New Delhi:  Aurobindo Pharma Ltd on Tuesday said it has set April 23 as the opening date for its Rs 800 crore buyback offer. The closing date for the buyback…

Boehringer Ingelheim launches AI centre for pharma research in London

Bengaluru: German drugmaker Boehringer Ingelheim is launching a ​centre for artificial ​intelligence and machine learning in London, it said ​on Monday, as it seeks to expand its AI capabilities in…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid